Massachusetts is grappling with an outbreak of Eastern Equine Encephalitis (EEE), a rare but deadly mosquito-borne virus. The state has reported its first human case of the year, leading to nighttime curfews, mosquito spraying, and public health advisories. The outbreak highlights the global challenge of controlling mosquito populations, which spread diseases like malaria and dengue.
The health department of Kerala has reported cases of West Nile fever in the districts of Kozhikode, Malappuram, and Thrissur. The state government has ordered all districts to be vigilant and has issued directives for mosquito control measures to be intensified. West Nile fever is a viral infection transmitted through the bites of infected mosquitoes, and it can cause a range of symptoms, including fever, headache, vomiting, and neurological complications. The health minister has urged citizens to seek immediate treatment if they experience any symptoms and has assured that there is no need for panic.
Malaria is a deadly disease transmitted by mosquitoes. On World Malaria Day, April 25th, we aim to raise awareness and empower communities to prevent and control this disease. By implementing simple preventive measures, such as using mosquito nets, repellents, and eliminating breeding grounds, we can significantly reduce the risk of malaria and save lives.
MosquitoMate, Inc., a leader in innovative mosquito control solutions, today announced that the United States Environmental Protection Agency (EPA) has granted registration for its revolutionary new product named “WB1 Males.” This new mosquito control pesticide represents a significant advancement in mosquito control. The WB1 pesticide specifically targets the mosquito, commonly known as the Yellow Fever mosquito, which is responsible for transmitting various diseases, including Zika, dengue, chickungunya, and Yellow Fever. The innovative new Wolbachia pesticide is unusual in that it consists of rearing and releasing male mosquitoes that are infected with a bacterium named ‘Wolbachia.’ The approach does not use chemicals or genetic modification and relies on a natural mechanism known as ‘Cytoplasmic Incompatibility’ (CI) to reduce the mosquito population. With the EPA’s new registration, MosquitoMate can now begin to roll out the WB1 males nationally, including US and Pacific territories, which have traditionally been impacted by diseases transmitted by the Yellow Fever mosquito. MosquitoMate, Inc. is now focused on the critical next steps: collaborating with state and local regulatory authorities to obtain the necessary permits for WB1 Male use in areas with the greatest need.
